Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
IWD2023 interview series, Feature Four: HaemaLogiX Chair/CEO, Bryce Carmine
Bryce Carmine is the Chairman and Chief Executive Officer with IR Department’s client, HaemaLogiX, a private Australian biotech company developing immune-based treatments for multiple myeloma.
We were grateful for Bryce giving us some time, as part of our International Women's Day series, to share some insights and perspective on this year’s theme, “Embracing Equity”.
Bryce Carmine is the Chairman and Chief Executive Officer with IR Department’s client, HaemaLogiX, a private Australian biotech company developing immune-based treatments for multiple myeloma.
We were grateful for Bryce giving us some time, as part of our International Women's Day series, to share some insights and perspective on this year’s theme, “Embracing Equity”.
When discussing recruitment of staff to retain diverse talent, Bryce stressed the importance of ensuring that your work environment is truly equitable across all areas. He is proud that HaemaLogiX meets both internal and market comparisons, irrespective of gender.
Bryce’s advice aligns with other interviewees. Despite the need for gender diversity, when recruiting, management need to identify candidates that offer the best experience and expertise.
CLICK HERE or on the video below to hear Bryce’s insights, including the importance of mentoring.
